Because IDO1 and TDO both lost their heme when cells were given a higher NO exposure, it is possible that inactivating IDO1 and TDO in this way through heme loss could diminish Kyn production and limit immune suppression, thereby enabling the T-cell differentiation that is needed to achieve tumor surveillance. The gene discussed is IDO1; the disease is neoplasm.